Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 16 de 16
Filtrar
Más filtros











Intervalo de año de publicación
1.
Clin Oral Investig ; 23(2): 577-584, 2019 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-29725846

RESUMEN

OBJECTIVES: The present study aimed to evaluate the efficacy of α-bisabolol (BISA)-based mouthwashes in the oral hygiene of patients submitted to oral and maxillofacial surgery. MATERIALS AND METHODS: A randomized, controlled, triple-blind clinical trial was conducted with 30 patients, undergoing oral and maxillofacial surgery. Three types of mouthwashes were developed, based at 0.12% chlorhexidine, 0.5% BISA, and 0.12% chlorhexidine + 0.5% BISA. The patients were evaluated in the preoperative and postoperative period, divided into three groups according to the mouthwash to be used. In the postoperative period, the oral hygiene quality of the patients was evaluated through the simplified oral hygiene index; the healing of the wounds was evaluated observing the presence of suture dehiscence and/or infection, and the pain was established using the Visual Analogue Scale. The antiseptic effect of the mouthwashes was evaluated in vitro. RESULTS: There were no differences in the efficacy of BISA-containing mouthwashes for oral hygiene, healing, and pain, compared to chlorhexidine based at 0.12%. There were no differences in the antiseptic activity of chlorhexidine and chlorhexidine + α-bisabolol-based mouthwashes. CONCLUSION: The results indicate that BISA-based mouthwashes have clinical efficacy, in the improvement of oral hygiene and wound healing, as well as in the reduction of postoperative pain. CLINICAL RELEVANCE: Considering that BISA has analgesic, antimicrobial, and anti-inflammatory properties, it is relevant to evaluate the efficacy of BISA-based mouthwashes in the oral hygiene of patients undergoing oral and maxillofacial surgery, seeking a better postoperative recovery.


Asunto(s)
Antiinfecciosos Locales/farmacología , Antisépticos Bucales/farmacología , Procedimientos Quirúrgicos Ortognáticos , Sesquiterpenos/farmacología , Adolescente , Adulto , Brasil , Clorhexidina/farmacología , Femenino , Humanos , Masculino , Persona de Mediana Edad , Sesquiterpenos Monocíclicos , Índice de Higiene Oral , Dimensión del Dolor , Dolor Postoperatorio/prevención & control , Espectroscopía Infrarroja por Transformada de Fourier
2.
Oral Dis ; 24(3): 377-383, 2018 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-28741807

RESUMEN

OBJECTIVE: The aim of this study was to evaluate the association of IL17A G197A polymorphism and serum levels with oral lichen planus (OLP) susceptibility and clinical presentation. SUBJECTS AND METHODS: Eighty-three individuals diagnosed with OLP and 99 healthy controls (C) were consecutively recruited. All participants had desquamating oral mucosal cells collected and DNA isolated for IL17A (G197A) genotyping. Blood samples of 42 OLP individuals and 23 healthy controls were collected for evaluation of IL17A serum levels. RESULTS: IL17A G197A genotypes were associated with an increased chance of having OLP (GA/AA × GG, OR = 3.44, 95% CI = 1.87-6.33, p < .001). Overall A carriers (GA or AA) were more common in OLP (38.1%) than in C (20.2%; OR = 2.43, 95% CI = 1.53-3.87, p < .001). Serum levels of IL17A were higher among patients with OLP than in healthy controls (reticular, p = .0003; erosive, p < .001), but no difference was found among the disease types. CONCLUSIONS: IL17A G197A is associated with a higher susceptibility of developing OLP and these patients seem to present a considerable increase in IL17A serum levels. These findings suggest that Th17 cells, and IL17A in particular, may play a pivotal role in OLP pathogenesis.


Asunto(s)
Interleucina-17/sangre , Interleucina-17/genética , Liquen Plano Oral/sangre , Liquen Plano Oral/genética , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Estudios de Casos y Controles , Femenino , Predisposición Genética a la Enfermedad/genética , Humanos , Masculino , Persona de Mediana Edad , Polimorfismo de Nucleótido Simple , Adulto Joven
3.
Sci Total Environ ; 574: 1622-1632, 2017 Jan 01.
Artículo en Inglés | MEDLINE | ID: mdl-27697337

RESUMEN

The iron isotope composition was used to investigate dissimilatory iron reduction (DIR) processes in an iron-rich waterlogged paddy soil, the iron uptake strategies of plants and its translocation in the different parts of the rice plant along its growth. Fe concentration and isotope composition (δ56Fe) in irrigation water, precipitates from irrigation water, soil, pore water solution at different depths under the surface water, iron plaque on rice roots, rice roots, stems, leaves and grains were measured. Over the 8.5-10cm of the vertical profiles investigated, the iron pore water concentration (0.01 to 24.3mg·l-1) and δ56Fe (-0.80 to -3.40‰) varied over a large range. The significant linear co-variation between Ln[Fe] and δ56Fe suggests an apparent Rayleigh-type behavior of the DIR processes. An average net fractionation factor between the pore water and the soil substrate of Δ56Fe≈-1.15‰ was obtained, taking the average of all the δ56Fe values weighted by the amount of Fe for each sample. These results provide a robust field study confirmation of the conceptual model of Crosby et al. (2005, 2007) for interpreting the iron isotope fractionation observed during DIR, established from a series of laboratories experiments. In addition, the strong enrichment of heavy Fe isotope measured in the root relative to the soil solution suggest that the iron uptake by roots is more likely supplied by iron from plaque and not from the plant-available iron in the pore water. Opposite to what was previously observed for plants following strategy II for iron uptake from soils, an iron isotope fractionation factor of -0.9‰ was found from the roots to the rice grains, pointing to isotope fractionation during rice plant growth. All these features highlight the insights iron isotope composition provides into the biogeochemical Fe cycling in the soil-water-rice plant systems studied in nature.

4.
Int J Oral Maxillofac Surg ; 45(2): 186-93, 2016 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-26458536

RESUMEN

The change in neurosensory lesions that develop after bilateral sagittal split osteotomy (BSSO) was explored, and the influence of the application of combination uridine triphosphate (UTP), cytidine monophosphate (CMP), and hydroxycobalamin (vitamin B12) on patient outcomes was assessed. This was a randomized, controlled, double-blind trial. The study sample comprised 12 patients, each evaluated on both sides (thus 24 sides). All patients fulfilled defined selection criteria. Changes in the lesions were measured both subjectively and objectively. The sample was divided into two patient groups: an experimental group receiving medication and a control group receiving placebo. The statistical analysis was performed using SPSS software. Lesions in both groups improved and no statistically significant difference between the groups was observed at any time. 'Severe' injuries in the experimental group were more likely to exhibit a significant improvement after 6 months. Based on the results of the present study, it is concluded that the combination UTP, CMP, and hydroxycobalamin did not influence recovery from neurosensory disorders.


Asunto(s)
Citidina Monofosfato/uso terapéutico , Hidroxocobalamina/uso terapéutico , Anomalías Maxilofaciales/cirugía , Osteotomía Sagital de Rama Mandibular , Trastornos de la Sensación/tratamiento farmacológico , Trastornos de la Sensación/etiología , Uridina Trifosfato/uso terapéutico , Complejo Vitamínico B/uso terapéutico , Adolescente , Adulto , Brasil , Estudios Transversales , Método Doble Ciego , Quimioterapia Combinada , Femenino , Humanos , Masculino , Estudios Prospectivos , Resultado del Tratamiento
5.
J Pediatr Adolesc Gynecol ; 25(3): 185-9, 2012 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-22297275

RESUMEN

OBJECTIVES: The objectives were to investigate the prevalence of adverse birth outcomes according to maternal age range in the city of Rio de Janeiro, Brazil, in 2002, and to evaluate the association between maternal age range and adverse birth outcomes using additive interaction to determine whether adequate prenatal care can attenuate the harmful effect of young age on pregnancy outcomes. METHODS: A cross-sectional analysis was performed in women up to 24 years of age who gave birth to live children in 2002 in the city of Rio de Janeiro. To evaluate adverse outcomes, the exposure variable was maternal age range, and the outcome variables were very preterm birth, low birth weight, prematurity, and low 5-minute Apgar score. The presence of interaction was investigated with the composite variable maternal age plus prenatal care. The proportions and respective 95% confidence intervals were calculated for adequate schooling, delivery in a public maternity hospital, and adequate prenatal care, and the outcomes according to maternal age range. The chi-square test was used. The association between age range and birth outcomes was evaluated with logistic models adjusted for schooling and type of hospital for each prenatal stratum and outcome. Attributable proportion was calculated in order to measure additive interaction. RESULTS: Of the 40,111 live births in the sample, 1.9% corresponded to children of mothers from 10-14 years of age, 38% from 15-19 years, and 59.9% from 20-24 years. An association between maternal age and adverse outcomes was observed only in adolescent mothers with inadequate prenatal care, and significant additive interaction was observed between prenatal care and maternal age for all the outcomes. CONCLUSION: Adolescent mothers and their newborns are exposed to greater risk of adverse outcomes when prenatal care fails to comply with current guidelines.


Asunto(s)
Edad Materna , Resultado del Embarazo , Embarazo en Adolescencia , Atención Prenatal/normas , Adolescente , Puntaje de Apgar , Brasil , Distribución de Chi-Cuadrado , Niño , Estudios Transversales , Femenino , Humanos , Recién Nacido de Bajo Peso , Recién Nacido , Recien Nacido Prematuro , Modelos Logísticos , Embarazo , Nacimiento Prematuro , Factores Socioeconómicos , Adulto Joven
6.
Oral Dis ; 15(8): 538-46, 2009 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-19619191

RESUMEN

The relationship between dentistry and medicine has been acknowledged throughout the history of humanity. This relationship was documented in ancient medicine accounts, and has survived until the present day, accompanied by the evolution of molecular technologies. Although we have had very important researchers' contributions in this interdisciplinary area, mainly after the 18th century, the knowledge on oral infections is still ignored by or unknown to the majority of clinical dentists and physicians. These circumstances could be changed through a broader divulgation of this complex relationship, both in the dentistry and in the medicine areas, which in turn would have a significant impact in systemic health worldwide. This movement has already started, as was observed in a World Health Assembly resolution which called for oral health to be integrated into chronic disease prevention programs in 2007. This was a significant indicator of changing perceptions of oral health over the past several decades. This brief review reports the evolution through time of the knowledge on the association between dental infections and systemic diseases, as well as the paths which we could take to consolidate this historical trend.


Asunto(s)
Infecciones Bacterianas/complicaciones , Infección Focal Dental/complicaciones , Historia de la Odontología , Enfermedades de la Boca/complicaciones , Sepsis/etiología , Infección Focal Dental/microbiología , Historia de la Medicina , Historia del Siglo XVIII , Historia del Siglo XIX , Historia del Siglo XX , Humanos , Relaciones Interprofesionales , Enfermedades de la Boca/microbiología
8.
Science ; 291(5509): 1685, 2001 Mar 02.
Artículo en Inglés | MEDLINE | ID: mdl-11253184
9.
Science ; 291(5501): 27, 2001 Jan 05.
Artículo en Inglés | MEDLINE | ID: mdl-11191994
10.
J Neurol Sci ; 150(1): 3-11, 1997 Sep 01.
Artículo en Inglés | MEDLINE | ID: mdl-9260852

RESUMEN

Benznidazole (N-benzyl-2-nitro-1-imidazoleacetamide) is an antiprotozoan agent of the nitroimidazole group used extensively in South America to treat Chagas' disease. In humans, its most important side effect is peripheral polyneuropathy, the frequency of which is dose related. To evaluate this effect, we administered benznidazole to adult, male, mongrel dogs at doses ranging from 5 to 40 mg/kg/day (0.5 to 4 times the dose used to treat chagasic patients). Subsequent neurological examination revealed apathy, ataxia, spastic tetraplegia with hyperreflexia of stretching reflexes, balance disorders and asymmetrical gait. These alterations appeared earlier and were more intense at the higher doses. Drug withdrawal also left dose- and time-dependent sequelae like ataxia, hypertonia, hyperreflexia and alterations of balance. No peripheral neuropathy was detected. The present findings suggest that a careful reevaluation of the side effects of benznidazole in humans is necessary.


Asunto(s)
Encefalopatías/inducido químicamente , Nervios Craneales/efectos de los fármacos , Neurotoxinas , Nitroimidazoles/toxicidad , Tripanocidas/toxicidad , Animales , Ataxia/inducido químicamente , Encefalopatías/fisiopatología , Nervios Craneales/fisiología , Nervios Craneales/fisiopatología , Perros , Relación Dosis-Respuesta a Droga , Humanos , Masculino , Actividad Motora/efectos de los fármacos , Postura , Cuadriplejía/inducido químicamente , Reflejo/efectos de los fármacos , Reflejo de Estiramiento/efectos de los fármacos
11.
J Neurol Sci ; 150(1): 13-25, 1997 Sep 01.
Artículo en Inglés | MEDLINE | ID: mdl-9260853

RESUMEN

We describe electroencephalographic (EEG) and morphological alterations in the CNS of dogs treated with benznidazole. The relationship between dose, duration of treatment and intensity of lesions observed was examined and used to establish anatomo-clinical associations. Two predominant EEG patterns were noted in treated dogs. Most of the animals (Group I) that received acute treatment with high doses (30 mg/kg/day) for 15 days followed by treatment at a lower dose (10 mg/kg/day) exhibited a type 2, EEG pattern, i.e., low voltage desynchronized with fast activity (LVFA). In contrast, most of the animals (Group II) that received short-term acute treatment with high doses (40 mg/kg/day) for 7 days followed by chronic treatment at lower doses (20 and 5 mg/kg/day) presented a type 1 EEG pattern. high voltage diffuse with slow activity (HVSA). Even after the drug was discontinued, the animals presented mild EEG alterations. These alterations. observed during and after treatment with benznidazole, suggest the presence of encephalopathy with multifocal characteristics. Several morphological alterations were observed in the animals, the most important being: lymphocytic inflammatory infiltrate, neuronal degeneration, satellitosis, demyelination and axonal degeneration, microglial proliferation, necrosis and gliosis. Such alterations involved the meninges, cerebral cortex, hemispheric white matter and subcortical gray matter, brain stem, cerebellum, and, less frequently, the spinal cord. No histopathological alterations were detected in the peripheral nerves. All encephalic levels were involved in all animals treated although the use of the high doses for 15 days (Group I) appeared to result in more lesions in the subcortical gray matter and the lower brainstem when compared to the use of high doses for 7 days (Group II) which led to greater involvement of the cerebral cortex, hemispheric white matter, cerebellum and medulla.


Asunto(s)
Encefalopatías/inducido químicamente , Encéfalo/efectos de los fármacos , Electroencefalografía/efectos de los fármacos , Neuronas/efectos de los fármacos , Nitroimidazoles/toxicidad , Nervios Periféricos/efectos de los fármacos , Tripanocidas/toxicidad , Animales , Encéfalo/patología , Encefalopatías/patología , Encefalopatías/fisiopatología , Cerebelo/efectos de los fármacos , Cerebelo/patología , Perros , Microglía/efectos de los fármacos , Microglía/patología , Degeneración Nerviosa , Neuronas/patología , Neurotoxinas , Nervios Periféricos/patología , Valores de Referencia
12.
Braz J Med Biol Res ; 23(8): 719-22, 1990.
Artículo en Inglés | MEDLINE | ID: mdl-2129270

RESUMEN

Benznidazole is used extensively throughout Latin America as an antiparasitic chemotherapeutic agent against chagasic infection. We have shown that rats chronically treated with 80 mg benznidazole kg-1 day-1 for 30 days present severe testicular atrophy and arrest of spermatogenesis. In the present experiments, plasma levels of testosterone (T), luteinizing hormone (LH), follicle stimulating hormone (FSH) and prolactin (Prl) were investigated in rats receiving 10, 40 and 80 mg benznidazole kg-1 day-1 for 30 days. No significant change in T, LH, or Prl levels was observed in treated rats (P greater than 0.05). Plasma FSH concentration, however, was markedly increased (P less than 0.05) by benznidazole treatment (40 and 80 mg kg-1 day-1) and remained high for 90 days after drug treatment was discontinued.


Asunto(s)
Antiprotozoarios/efectos adversos , Hormona Folículo Estimulante/sangre , Hormona Luteinizante/sangre , Nitroimidazoles/efectos adversos , Prolactina/sangre , Testículo/efectos de los fármacos , Testosterona/sangre , Animales , Masculino , Ratas
13.
Rev. bras. pesqui. méd. biol ; Braz. j. med. biol. res;23(8): 719-22, 1990. tab
Artículo en Inglés | LILACS | ID: lil-92329

RESUMEN

Benznidazole is used extensively throughout Latin America as an antiparasitic chemotherapeutic agent against chagasica infection. We have shown that rats chronically treated with 80 mg benznidazole Kg-1 day-1 for 30, days present severe testicular atrophy and arrest of spermatognesis. In the present experiments, plasma levels of testosterone (T), luteinizing hormone (LH), follicle stimulating hormone (FSH) and prolactin (Prl- were inbestigated in rats receiving 10, 40 and 80 mg benznidazole Kg-1 day-1 for 30 days. No significant change in T, LH or Prl levels was observed in treated rats (P > 0.05). Plasma FSH concentration, however, was markedly invreased (P < 0.05 by benzidazole treatment (40 and 80 mgKg-1 day-1) and remained high for 90 days after drug treatment was discontinued


Asunto(s)
Ratas , Antiprotozoarios/farmacología , Bencimidazoles/farmacología , Hormona Folículo Estimulante/sangre , Hormona Luteinizante/sangre , Prolactina/sangre , Testosterona/sangre , Ratas Wistar , Testículo/efectos de los fármacos
15.
Braz J Med Biol Res ; 22(6): 695-8, 1989.
Artículo en Inglés | MEDLINE | ID: mdl-2620178

RESUMEN

To determine the side effects of benznidazole, an antiparasitic chemotherapeutic agent against chagasic infection, rats were treated with 80 mg benznidazole kg-1 day-1, p.o., for 30 days, while controls received the vehicle. Treated animals developed severe testicular atrophy (0.25 +/- 0.02 g/100 g vs 0.44 +/- 0.02 g/100 g for the controls), though plasma testosterone level, relative weight of seminal vesicles and prostate were similar to those of the controls. Histological examination of the testes revealed a statistically significant alteration in the spermatogenic process with a marked decrease in the frequency of meiosis, number of tubular sections with mature spermatids and depletion of germinal epithelium.


Asunto(s)
Nitroimidazoles/uso terapéutico , Espermatogénesis/efectos de los fármacos , Testículo/patología , Tripanocidas , Animales , Atrofia , Masculino , Tamaño de los Órganos/efectos de los fármacos , Próstata/patología , Ratas , Ratas Endogámicas , Vesículas Seminales/patología , Testosterona/sangre
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA